Why attend?
The 2025 ISPE Facilities of the Future Conference brings together pharmaceutical industry stakeholders, particularly those concerned with planning, designing, constructing, manufacturing, supplying, and assessing innovative “next generation” facilities and related pharmaceutical engineering innovations, processes, and practices.
This conference will address the latest advancements in manufacturing and cutting-edge digital advancements, sustainability initiatives in new and legacy facilities, and strategies for cultivating the workforce of the future. In addition, explore the transformation of existing facilities; current design trends and delivery methods for new facilities, laboratories, and warehouses; and the challenges and regulatory frameworks shaping the pharmaceutical industry.
Why Attend an ISPE Facilities of the Future Conference?
Network with Key Industry Professionals
Featured Speakers
SVP Head of Global Engineering
Takeda Pharmaceuticals International AG
Director, Enterprise Project Staff
CDER/OPQ/OQA/PMS
Senior Vice President – Corporate Operations and Chief Sustainability Officer
Gilead Sciences, Inc.
EVP, Chief Technology Officer, and Head of Research & Development
ConvaTec
Sr. Vice President, Device & Packaging Operations Manufacturing
Eli Lilly And Company
Your Conference Experience
Expo Hall
Expo Hall
Explore groundbreaking innovations and network with industry leaders at our dynamic expo hall.
Networking
Networking
Connect with top industry experts and expand your professional network at our exclusive networking sessions.
Live Streams
Live Streams
Experience the conference from anywhere with our interactive live stream.
On-Demand Content
On-Demand Content
Access exclusive conference content anytime with our on-demand library for 90 days.
Conference Highlights
Message From the Chair: Why Attend the 2025 ISPE Facilities of the Future Conference
The 2025 Facilities of the Future Conference will explore innovations in facility design and delivery, emerging trends in technologies, manufacturing, and support areas such as laboratories and warehousing. Also included are the ways technology and digital transformation will impact the workforce of the future, and sustainability efforts in both new and legacy pharmaceutical facilities.
International Program Committee
Chair
CEO
CAI
International Board Liaison
Executive Chairman of the Board
CRB
Foundation Board Liaison
Vice President, Global Engineering and Technology
Johnson & Johnson Innovative Medicines
Chapter Liaison
Director of Marketing and Business Development
Total Validation Services, Inc.
Women in Pharma Liaison
Vice President - Cockram USA
Cockram Construction Inc
Vice President of Global Engineering
Catalent Pharma Solutions
Director, Product Operations Strategy and Business Lead
Takeda
Sr. Director- Strategic Talent Partnerships
Eli Lilly and Company
Technical Director, Group Head of Technology
PM Group
Director of Sales and Business Development
GMP Systems Inc
Senior Director, Business Development
CRB
Emerging Leader
Sr. Engineer - API, Lebanon Plant 1 (LP1)
Eli Lilly & Company